Skip to main content

Table 1 Baseline characteristics of the study population

From: Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial

Characteristic

TG

 

IG

 

CG

 

p-value

n

%

 

n

%

 

n

%

  

Medical history

          

Pathogenic variant

417

100

 

216

100

 

201

100

  

BRCA1a

233

55.9

 

124

57.4

 

109

54.2

 

0.572

BRCA2

178

42.7

 

88

40.7

 

90

44.8

 

BRCA1 and BRCA2

6

1.4

 

4

1.9

 

2

1.0

 

Own cancer history

417

100

 

216

100

 

201

100

  

(A) No history of cancer (previvors)

292

70.0

 

157

72.7

 

135

67.2

 

0.219

(B) History of unilateral BC (survivors)

125

30.0

 

59

27.3

 

66

32.8

 

Recruitment at

417

100

 

216

100

 

201

100

 

PTGC

142

34.1

 

81

37.5

 

61

30.3

 

0.124

IBS/IBSA

275

65.9

 

135

62.5

 

140

69.7

 

Time since genetic test result

401

100

 

209

100

 

192

100

 

≤ 1 year

189

47.1

 

106

50.7

 

83

43.2

 

0.324

> 1 to ≤ 5 years

142

35.4

 

69

33.0

 

73

38.0

 

> 5 years

70

17.5

 

34

16.3

 

36

18.8

 

Own children

415

100

 

215

100

 

200

100

  

Yes

243

58.6

 

121

56.3

 

122

61.0

 

0.329

No

172

41.4

 

94

43.7

 

78

39.0

 

Family planning completed

414

100

 

214

100

 

200

100

 

Yes

229

55.3

 

103

48.1

 

126

63.0

 

0.010*

No

159

38.4

 

96

44.9

 

63

31.5

 

Not specified

26

6.3

 

15

7.0

 

11

5.5

 

Demographics

          

Mean Age (years) [SD]

39.8

[11.4]

 

38.2

[11.3]

 

41.4

[11.2]

  

Age group (years)

417

100

 

216

100

 

201

100

  

18–40

236

56.6

 

139

64.4

 

97

48.3

 

0.001*

> 40

181

43.4

 

77

35.6

 

104

51.7

 

Marital status

415

100

 

216

100

 

199

100

  

Married/relationship

243

58.6

 

123

56.9

 

120

60.0

 

0.488

Single/separated/divorced/widowed

172

41.4

 

93

43.1

 

79

39.7

 

Highest vocationally relevant degree

416

100

 

216

100

 

200

100

  

Academicb

162

38.9

 

82

38.0

 

80

40.0

 

0.670

Not academicc

254

61.1

 

134

62.0

 

120

60.3

 

Employment status

415

100

 

216

100

 

199

100

  

Employedd

284

68.4

 

142

65.7

 

142

71.4

 

0.219

Not employede

131

31.6

 

74

34.3

 

57

28.6

 
  1. aone participant with a pathogenic BRCA1 variant also had a pathogenic CHEK2 variant
  2. bincludes: university degree, university of applied science degree
  3. cincludes: no degree, middle/intermediate school certification, final/technical high school certification
  4. dincludes: full/part time employment
  5. eincludes: school/training/studies, parental leave, unemployed, not able to work, retired, temporary job, not specified
  6. *statistically significant difference between IG and CG (Pearson’s chi-square test).
  7. BC: breast cancer; PTGC: posttest genetic counseling; IBS/IBSA: intensified breast surveillance (and aftercare);
  8. TG: total group (IG and CG); IG: intervention group; CG: control group.